FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979287595> ?p ?o ?g. }

• W1979287595 endingPage "513" @default.
• W1979287595 startingPage "506" @default.
• W1979287595 abstract "Universal nevirapine (NVP) therapy (provision of the drug without HIV testing) has been suggested as potentially superior to targeted NVP therapy (provision of the drug to seropositive patients identified through voluntary HIV counseling and testing [VCT]) for perinatal HIV prevention in low-resource, high-prevalence settings. The authors postulated that uptake (the proportion of women who accept the strategy when offered) may be higher for universal therapy, since it does not require a woman to learn her serostatus; they further postulated that adherence (the proportion of women who actually ingest the NVP tablet at labor onset) may be higher for targeted therapy, since knowledge of serostatus could motivate better adherence. Two clinics in Lusaka, Zambia were assigned to provide either the targeted or universal strategy. Halfway through the study period, the approach offered at each clinic was crossed over. Adherence was assessed by liquid chromatographic assay for NVP of cord blood. Regarding uptake, 1524 pregnant women were offered participation, and 1025 (67%) accepted. Of 694 women offered enrollment in the universal strategy, 496 (71%) accepted; of 830 women offered enrollment in the targeted strategy, 529 (64%) accepted (p <.01). Uptake was similar at both clinics for the universal strategy: 250 of 339 (74%) at clinic A and 246 of 355 (69%) at clinic B (p =.2), but differed significantly between clinics for the targeted strategy: 229 of 316 (72%) at clinic A and 300 of 514 (58%) at clinic B (RR, 1.51; 95% CI, 1.23, 1.86). Increased uptake correlated with having been offered the universal rather than the targeted strategy (AOR, 1.5; 95% CI, 1.1, 2.1), attendance at clinic A (AOR, 1.4; 95% CI, 1.01, 2.0), and maternal report of a prior fetal or infant death (AOR, 1.6; 95% CI, 1.1, 2.5). Regarding adherence, in the universal strategy, 40 of 103 women (39%) were nonadherent compared with 25 of 98 women (26%) in the targeted strategy (RR, 1.5; 95% CI, 1.004, 2.3). Failure to adhere correlated with participation in the universal strategy (AOR, 2.0; 95% CI, 1.04, 4.2) and illiteracy (AOR, 2.6; 95% CI, 1.2, 5.3). In high-prevalence settings with adequate VCT services, uptake of NVP using the universal or targeted approach appears comparable. However, the universal strategy may result in better uptake in clinics with less well-functioning VCT services (as with clinic B). Adherence to the single-dose NVP intervention was lower among women who did not learn their HIV status. Programs that seek to save the greatest possible number of infants from perinatal HIV acquisition should consider a combination approach, in which women who desire HIV testing can access NVP through a targeted strategy, and women who do not desire testing can access NVP through a universal strategy." @default.
• W1979287595 created "2016-06-24" @default.
• W1979287595 creator A5005976503 @default.
• W1979287595 creator A5017415232 @default.
• W1979287595 creator A5019896304 @default.
• W1979287595 creator A5031448084 @default.
• W1979287595 creator A5075363206 @default.
• W1979287595 creator A5075699342 @default.
• W1979287595 creator A5078059377 @default.
• W1979287595 creator A5081259784 @default.
• W1979287595 date "2003-04-01" @default.
• W1979287595 modified "2023-10-11" @default.
• W1979287595 title "Comparison of Two Strategies for Administering Nevirapine to Prevent Perinatal HIV Transmission in High-Prevalence, Resource-Poor Settings" @default.
• W1979287595 cites W185743922 @default.
• W1979287595 cites W1976976459 @default.
• W1979287595 cites W1986387230 @default.
• W1979287595 cites W2081291061 @default.
• W1979287595 cites W2101195795 @default.
• W1979287595 cites W2137423832 @default.
• W1979287595 cites W2151211179 @default.
• W1979287595 cites W2154279617 @default.
• W1979287595 cites W2170947401 @default.
• W1979287595 cites W4230209008 @default.
• W1979287595 cites W4235133654 @default.
• W1979287595 doi "https://doi.org/10.1097/00126334-200304150-00007" @default.
• W1979287595 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2745994" @default.
• W1979287595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12679702" @default.
• W1979287595 hasPublicationYear "2003" @default.
• W1979287595 type Work @default.
• W1979287595 sameAs 1979287595 @default.
• W1979287595 citedByCount "62" @default.
• W1979287595 countsByYear W19792875952012 @default.
• W1979287595 countsByYear W19792875952013 @default.
• W1979287595 countsByYear W19792875952014 @default.
• W1979287595 countsByYear W19792875952015 @default.
• W1979287595 countsByYear W19792875952018 @default.
• W1979287595 countsByYear W19792875952021 @default.
• W1979287595 crossrefType "journal-article" @default.
• W1979287595 hasAuthorship W1979287595A5005976503 @default.
• W1979287595 hasAuthorship W1979287595A5017415232 @default.
• W1979287595 hasAuthorship W1979287595A5019896304 @default.
• W1979287595 hasAuthorship W1979287595A5031448084 @default.
• W1979287595 hasAuthorship W1979287595A5075363206 @default.
• W1979287595 hasAuthorship W1979287595A5075699342 @default.
• W1979287595 hasAuthorship W1979287595A5078059377 @default.
• W1979287595 hasAuthorship W1979287595A5081259784 @default.
• W1979287595 hasBestOaLocation W19792875952 @default.
• W1979287595 hasConcept C119599485 @default.
• W1979287595 hasConcept C126322002 @default.
• W1979287595 hasConcept C127413603 @default.
• W1979287595 hasConcept C142462285 @default.
• W1979287595 hasConcept C187212893 @default.
• W1979287595 hasConcept C2775832928 @default.
• W1979287595 hasConcept C2776535787 @default.
• W1979287595 hasConcept C2779130552 @default.
• W1979287595 hasConcept C2993143319 @default.
• W1979287595 hasConcept C3013748606 @default.
• W1979287595 hasConcept C512399662 @default.
• W1979287595 hasConcept C71924100 @default.
• W1979287595 hasConcept C761482 @default.
• W1979287595 hasConceptScore W1979287595C119599485 @default.
• W1979287595 hasConceptScore W1979287595C126322002 @default.
• W1979287595 hasConceptScore W1979287595C127413603 @default.
• W1979287595 hasConceptScore W1979287595C142462285 @default.
• W1979287595 hasConceptScore W1979287595C187212893 @default.
• W1979287595 hasConceptScore W1979287595C2775832928 @default.
• W1979287595 hasConceptScore W1979287595C2776535787 @default.
• W1979287595 hasConceptScore W1979287595C2779130552 @default.
• W1979287595 hasConceptScore W1979287595C2993143319 @default.
• W1979287595 hasConceptScore W1979287595C3013748606 @default.
• W1979287595 hasConceptScore W1979287595C512399662 @default.
• W1979287595 hasConceptScore W1979287595C71924100 @default.
• W1979287595 hasConceptScore W1979287595C761482 @default.
• W1979287595 hasIssue "5" @default.
• W1979287595 hasLocation W19792875951 @default.
• W1979287595 hasLocation W19792875952 @default.
• W1979287595 hasLocation W19792875953 @default.
• W1979287595 hasLocation W19792875954 @default.
• W1979287595 hasOpenAccess W1979287595 @default.
• W1979287595 hasPrimaryLocation W19792875951 @default.
• W1979287595 hasRelatedWork W2003666163 @default.
• W1979287595 hasRelatedWork W2048864317 @default.
• W1979287595 hasRelatedWork W2075010788 @default.
• W1979287595 hasRelatedWork W2124140405 @default.
• W1979287595 hasRelatedWork W2138426110 @default.
• W1979287595 hasRelatedWork W2327545648 @default.
• W1979287595 hasRelatedWork W4250316256 @default.
• W1979287595 hasRelatedWork W4300886121 @default.
• W1979287595 hasRelatedWork W4301807426 @default.
• W1979287595 hasRelatedWork W4302072235 @default.
• W1979287595 hasVolume "32" @default.
• W1979287595 isParatext "false" @default.
• W1979287595 isRetracted "false" @default.
• W1979287595 magId "1979287595" @default.
• W1979287595 workType "article" @default.